Trial Profile
Metabolic effects of ethinylestradiol/dienogest and metformin in non-obese patients with polycystic ovarian syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Feb 2015
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/dienogest (Primary) ; Metformin (Primary)
- Indications Polycystic ovary syndrome
- Focus Pharmacodynamics
- 18 Feb 2015 New trial record